Medicare Advantage Challenges: 2023 Stent Declines Medigap Access
Published on 8/1/2026

AI Summary
Summarized by AI from the source belowA 71-year-old Florida widow faced difficulties switching from her Medicare Advantage plan after a stent was placed in 2023, leading to denials from insurers for Medigap Plan G. Federal law allows a guaranteed-issue window for Medigap for six months starting at age 65 with Part B enrollment. After this period, carriers can evaluate medical histories, which may result in declined applications based on conditions like recent stents or high blood pressure. This situation highlights important factors for retirees considering their health coverage options in relation to Medicare plans, which may significantly impact their financial planning.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
Related News

Medicare to Change Drug Program, Impacting Premiums for Seniors
Aug 1

Mustang Sale Triggers $85K Tax Impact and Medicare Premium Spike
Aug 1

Boston Scientific stock down 0.4% on market changes
Jul 31

Siemens Healthineers Q3 FY2026 Orders Strong Despite Weak Diagnostics
Jul 31